FDA Scientists Collide with FDA Managers Re: Safety Issues

Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs. Continue reading →

Unexamined Drug Epidemic–the Elephant No One Wants to See

us_troops.jpg

“Prescription drug therapy stands as one of the most significant perils to health resulting from human activity.” What’s the FDA doing to stem the tide of this preventable epidemic? Continue reading →

Vicissitudes of Psychiatry’s Diagnostic Manual Revisions

The latest area of controversy focuses on the proposed revision of the definition "behavioral addiction disorder" extending the addiction diagnosis to include drug, alcohol and gambling.  It is estimated that the change would expand the number of people labeled as "addicts" by 20 to 30 million who would be entitled to treatment and disability payments costing taxpayers many hundreds of millions of dollars. Continue reading →

Nobody Should Volunteer for Clinical Trials As Long As Research Data Is Secret

An urgent call for a debate about the ethics of data secrecy. Absent the humanitarian raison d’etre for enrolling in a clinical trial, no human being should be put at any–even minimal risk–without adequate compensation as a laborer and the protection of Workmen’s Compensation insurance.   

Continue reading →

Presidential Panel Condemns US Syphilis Study in Guatemala

nyt_syphilis-news_clip_1947.jpg

  A year after professor Susan M. Reverby, a historian at Wellesley College in Massachusetts, uncovered a heinous Guatemalan syphilis experiment conducted between 1946 and 1948, on at least 5,500 under the auspices of the US Public Health Service, a hearing was . . . Continue reading →

Where Can One Find an Honest, Forthright Psychiatrist?

Following our March 15 Infomail/ post, "Inside Psychiatry’s Battle to Define Mental Illness," we received an e-mail from Dr. Allen Frances, objecting–in essence retracting his statements in an article in WIRED magazine by  Gary Greenverg.  Our response to Dr. Frances follows his communication. 

Continue reading →